Substantive final action
HB870
House Vote on HB 870 FINAL PASSAGE (#466)
Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
Passed House April 13, 2026⭐ Substantive final action
Yea (96)
Absent (9)
Republicans (73)
100% yea among members casting a yea or nay vote (71–0).
Democrats (32)
100% yea among members casting a yea or nay vote (25–0).